scispace - formally typeset
T

Thomas J. McLaughlin

Researcher at University of Massachusetts Medical School

Publications -  100
Citations -  6967

Thomas J. McLaughlin is an academic researcher from University of Massachusetts Medical School. The author has contributed to research in topics: Addiction & Medicine. The author has an hindex of 37, co-authored 88 publications receiving 6623 citations. Previous affiliations of Thomas J. McLaughlin include Harvard University & McLean Hospital.

Papers
More filters
Journal ArticleDOI

The Future is Now for Precision Genomic Addiction Medicine as a Frontline Modality for Inducing "Dopamine Homeostasis" in Reward Deficiency Syndrome (RDS).

TL;DR: In this genomic era of addiction medicine, ideal treatment planning begins with genetic screening to determine neurogenetic antecedents of the Reward Deficiency Syndrome (RDS) phenotype as mentioned in this paper .
Journal ArticleDOI

Genetic Addiction Risk Severity Assessment Identifies Polymorphic Reward Genes as Antecedents to Reward Deficiency Syndrome (RDS) Hypodopaminergia’s Effect on Addictive and Non-Addictive Behaviors in a Nuclear Family

TL;DR: In this article , a case series presented the novel genetic addiction risk score (GARS), which shows a high prevalence of polymorphic risk alleles of reward genes in a nuclear family with multiple reward deficiency syndrome (RDS) behavioral issues expressing a hypodopaminergic antecedent.
Journal Article

Futuristic Thinking about Engineering "Geneospirituality" to Help Prevent Relapse of Reward Deficiency Syndrome (RDS) Behaviors.

TL;DR: In this article , the authors discuss and review some potential futuristic concepts and technological advancements in terms of geneospirituality engineering to help prevent relapse and or even protect against an unwanted predisposition to RDS behaviors.